Psychometric properties of the QLQ-C30 (version 3.0) in a sample of ambulatory Cretan cancer patients: Original article

European Journal of Cancer Care

Volumn 18, Issue 5, 2009, Pages 447-456

  Koukouli, S ^a   Stamou, A ^b   Alegakis, A ^b   Georgoulias, V ^b   Samonis, G ^b  

^a TECHNOLOGICAL EDUCATIONAL INSTITUTE OF CRETE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Cancer; Cultural adaptation; Heterogeneous samples; QLQ C30 (version 3.0); Quality of life; Subjective measurement tools

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; COLORECTAL TUMOR; DAILY LIFE ACTIVITY; DISEASE COURSE; EVALUATION; FEMALE; GREECE; HEALTH STATUS; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; STANDARD;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GREECE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 69149104292     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00934.x     Document Type: Article

References (26)

1. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Flechtner H., Fleishman S.B., De Haes J.C.J.M., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P.B., Schraub S., Sneeuw K., Sullivan M. Takeda F. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal Of The National Cancer Institute 85, 365 376.
2. Bergman B., Sullivan M. Sorenson S. (1992) Quality of life during chemotherapy for small cell lung cancer II. A longitudinal study of the EORTC Core Questionnaire and comparison with the Sickness Impact Profile. Acta Oncologica 31, 19 28.
3. Blagden S.P., Charman S.C., Sharples L.D., Magee L.R. Gilligan D. (2003) Performance status score: do patients and their oncologists agree? British Journal of Cancer 89, 1022 1027.
4. Cheung Y.B., Goh C., Thumboo J., Khoo K.-S. Wee J. (2006) Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. Journal of Clinical Epidemiology 59, 185 191.
5. Cohen S.R., Mount B.M., Strobel M.G. Bui F. (1995) The McGill quality of life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliative Medicine 9, 207 219.
6. Cronbach L.J. (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16, 297 334.
7. Dirmaier J., Zaun S., Koch U., Harfst T. Schulz H. (2004) Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany. Palliative and Supportive Care 2, 115 124.
8. Fayers P., Aaronson N., Bjordal K., Groenvold M., Curran D. Bottomley A. (2001) EORTC QLQ-C30 scoring manual, EORTC Quality of Life Group 3rd edn. EORTC, Brussels, Belgium.
9. Guzelant A., Goskel T., Ozkok S., Tasbakan S., Aysan T. Bottomley A. (2004) The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC-C30. European Journal of Cancer Care 13, 135 144.
10. Hearn J. Higginson I. (1997) Outcome measures in palliative care for advanced cancer patients: a review. Journal of Public Health Medicine 19, 193 199.
11. Hoopman R., Muller M.J., Terwee C.B. Aaronson N.K. (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. European Journal of Cancer 42, 1839 1847. (Pubitemid 44149081)
12. Kobayashi A.K., Takeda F., Teramukai S., Gotoh I., Sakai H., Yoneda S., Noguchi Y., Ogasawara H. Yoshida K. (1998) Cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with Lung Cancer. European Journal of Cancer 34, 810 815.
13. Kyriaki M., Eleni T., Efi P., Ourania K., Vassilios S. Lambros V. (2001) The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. International Journal of Cancer 94, 135 139.
14. Ringdal G.I. Ringdal K. (1993) Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Quality of Life Research 2, 129 140.
15. Schipper H., Clinch J. McMurray A. (1984) Measuring the quality of life of cancer patients. The Functional Living Index-Cancer: development and validation. Journal of Clinical Oncology 2, 472 483.
16. Slevin M.L., Plant H., Lynch D., Drinkwater J. Gregory W.M. (1988) Who should measure quality of life, the doctor or the patient? British Journal of Cancer 57, 109 112.
17. Sorensen J.B., Klee M., Palshof T. Hansen H.H. (1993) Performance status assessment in cancer patients. An inter-observer variability study. British Journal of Cancer 67, 773 775.
18. Spitzer W.O., Dobson A.J. Hall J. (1981) Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. Journal of Chronic Diseases 34, 585 597.
19. Sprangers M.A.G. Aaronson N.K. (1992) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. Journal of Clinical Epidemiology 45, 743 760.
20. Sprangers M.A.G., Cull A., Bjordal K., Groenvold M. Aaronson N.K. (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Quality of Life Research 2, 287 295.
21. Stephens R.J., Hopwood P., Girling D.J. Machin D. (1997) Randomized trials with quality of life end-points: are doctors' ratings of the patients' physical symptoms interchangeable with patients' self-ratings? Quality of Life Research 6, 225 236.
22. Stewart A. Napoles-Springer A. (2000) Health-Related-Quality-of-Life assessments in diverse population groups in the United States. Medical Care 38, II-102 II-124.
23. Wiklund I., Dimenas E. Wahl M. (1990) Factors of importance when evaluating quality of life in clinical trials. Controlled Clinical Trials 11, 169 179.
24. Wu A.W. (2000) Quality-of-Life assessment in clinical research. Application in diverse populations. Medical Care 38, II-130 II-135.
25. Zhao H. Kanda K. (2000) Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Quality of Life Research 9, 129 137.
26. Zubrod C.G., Scheiderman M., Frei E., Brindley C., Gold G.L., Shnider B., Oviedo R., Gorman J., Jones R., Jonsson U., Colsky J., Chalmers T., Ferguson B., Dederick M., Holland J., Selawry O., Regelson W., Lasagna L. Owens A.H. (1960) Cancer-appraisal of methods for the study of chemotherapy of cancer in men: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases 11, 7 33.